Investing Profile

Sanne Weijzen

InvestorVC
Partner at Aglaia Oncology Funds
Photo of Sanne Weijzen, Partner at Aglaia Oncology Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
5844 CONNECTIONS
Hotmail Network
5844 CONNECTIONS
LBW Consulting Network
739 CONNECTIONS
LBW Consulting Network
739 CONNECTIONS
LBW Consulting Network
739 CONNECTIONS
$100K - $5.0M
$1.5M
Member of the Supervisory Board LBW ConsultingPresent
Ad-interim Chairman of the Supervisory Board LBW ConsultingPresent
Owner LBW ConsultingPresent
VP, Head of Corporate Strategy and EU Operations Neogene TherapeuticsPresent
VP Corporate Strategy and Head EU Operations Neogene TherapeuticsPresent
VP, Head of Corporate Strategy and Global Operations, member of the Executive Committee Neogene TherapeuticsPresent
Member of The Supervisory Board LBW ConsultingPresent
Head of Cell Therapy Business and portfolio strategy AstraZenecaPresent
Post-doc Dept. of Physiological Chemistry UMC UtrechtPresent
Business Analyst Aglaia Oncology FundsPresent
Investment Manager Aglaia Oncology FundsPresent
Member of the Supervisory Board InteRNA Technologies BVPresent
Ad-interim Chairman of the Supervisory Board InteRNA Technologies BVPresent
Owner HotmailPresent
COO Scenic BiotechPresent
VP, Head of Corporate Strategy and Global Operations Neogene TherapeuticsPresent
Member of The Supervisory Board HotmailPresent
Head of Corporate Strategy, Cell Therapy AstraZenecaPresent
Partner Aglaia Oncology FundsPresent
Leiden University Master of Science - MS Biomedical Sciences
Thoraxcenter, Erasmus University Medical Center PhD Cancer Immunology/Tumor Biology
Sign in with Google →
Sign in with Google →